Emma Nozza

Milan, 20122, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

IGF2R: a new player in the IGF2 loop sustaining adrenocortical carcinogenesis.

IGF2R: a new player in the IGF2 loop sustaining adrenocortical carcinogenesis.

Journal: Cell communication and signaling : CCS

Published: February 18, 2026

Pan-CDK and PLK1 inhibitors as a novel approach for targeted treatment of adrenocortical carcinomas.

Pan-CDK and PLK1 inhibitors as a novel approach for targeted treatment of adrenocortical carcinomas.

Journal: European journal of endocrinology

Published: October 16, 2025

The Cytoskeleton in Adrenal Physiology and Tumours: Functional Roles and Emerging Molecular Targets.

The Cytoskeleton in Adrenal Physiology and Tumours: Functional Roles and Emerging Molecular Targets.

Journal: International journal of molecular sciences

Published: September 11, 2025

Preclinical evaluation of the antitumoral efficacy of Wee1 inhibitor AZD1775 in adrenocortical carcinoma.

Preclinical evaluation of the antitumoral efficacy of Wee1 inhibitor AZD1775 in adrenocortical carcinoma.

Journal: Pharmacological research

Published: August 07, 2025

Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas.

Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas.

Journal: Cell communication and signaling : CCS

Published: October 08, 2024

Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas.

Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas.

Journal: International journal of cancer

Published: July 03, 2024

The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells.

The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells.

Journal: International journal of molecular sciences

Published: February 08, 2024

Redox-activity and in vitro effects of regional atmospheric aerosol pollution: Seasonal differences and correlation between oxidative potential and in vitro toxicity of PM1.

Redox-activity and in vitro effects of regional atmospheric aerosol pollution: Seasonal differences and correlation between oxidative potential and in vitro toxicity of PM1.

Journal: Toxicology and applied pharmacology

Published: January 08, 2024

High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study.

High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study.

Journal: International journal of molecular sciences

Published: October 03, 2023

A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells.

A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells.

Journal: Cancers

Published: April 17, 2023

Toxicological Profile of PM from Different Sources in the Bronchial Epithelial Cell Line BEAS-2B.

Toxicological Profile of PM from Different Sources in the Bronchial Epithelial Cell Line BEAS-2B.

Journal: Toxics

Published: March 27, 2023

P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs.

P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs.

Journal: Cancers

Published: March 22, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026